The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Rabies Vaccination Market Research Report 2025
Synopsis
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
The global Human Rabies Vaccination market was valued at US$ 1112 million in 2023 and is anticipated to reach US$ 1489.5 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccination.
Report Scope
The Human Rabies Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rabies Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Segment by Application
Pre-exposure
Post-exposure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rabies Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rabies Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
The global Human Rabies Vaccination market was valued at US$ 1112 million in 2023 and is anticipated to reach US$ 1489.5 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccination.
Report Scope
The Human Rabies Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rabies Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Segment by Application
Pre-exposure
Post-exposure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rabies Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rabies Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Rabies Vaccination Market Overview
1.1 Product Overview and Scope of Human Rabies Vaccination
1.2 Human Rabies Vaccination Segment by Type
1.2.1 Global Human Rabies Vaccination Market Value Comparison by Type (2024-2030)
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Human Rabies Vaccination Segment by Application
1.3.1 Global Human Rabies Vaccination Market Value by Application: (2024-2030)
1.3.2 Pre-exposure
1.3.3 Post-exposure
1.4 Global Human Rabies Vaccination Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Vaccination Revenue 2019-2030
1.4.2 Global Human Rabies Vaccination Sales 2019-2030
1.4.3 Global Human Rabies Vaccination Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Rabies Vaccination Market Competition by Manufacturers
2.1 Global Human Rabies Vaccination Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Rabies Vaccination Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Rabies Vaccination Average Price by Manufacturers (2019-2024)
2.4 Global Human Rabies Vaccination Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rabies Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rabies Vaccination, Product Type & Application
2.7 Human Rabies Vaccination Market Competitive Situation and Trends
2.7.1 Human Rabies Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Rabies Vaccination Players Market Share by Revenue
2.7.3 Global Human Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rabies Vaccination Retrospective Market Scenario by Region
3.1 Global Human Rabies Vaccination Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Rabies Vaccination Global Human Rabies Vaccination Sales by Region: 2019-2030
3.2.1 Global Human Rabies Vaccination Sales by Region: 2019-2024
3.2.2 Global Human Rabies Vaccination Sales by Region: 2025-2030
3.3 Global Human Rabies Vaccination Global Human Rabies Vaccination Revenue by Region: 2019-2030
3.3.1 Global Human Rabies Vaccination Revenue by Region: 2019-2024
3.3.2 Global Human Rabies Vaccination Revenue by Region: 2025-2030
3.4 North America Human Rabies Vaccination Market Facts & Figures by Country
3.4.1 North America Human Rabies Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Rabies Vaccination Sales by Country (2019-2030)
3.4.3 North America Human Rabies Vaccination Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Rabies Vaccination Market Facts & Figures by Country
3.5.1 Europe Human Rabies Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Rabies Vaccination Sales by Country (2019-2030)
3.5.3 Europe Human Rabies Vaccination Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Human Rabies Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Rabies Vaccination Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Rabies Vaccination Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Rabies Vaccination Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Rabies Vaccination Sales by Country (2019-2030)
3.7.3 Latin America Human Rabies Vaccination Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Rabies Vaccination Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Rabies Vaccination Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Rabies Vaccination Sales by Type (2019-2030)
4.1.1 Global Human Rabies Vaccination Sales by Type (2019-2024)
4.1.2 Global Human Rabies Vaccination Sales by Type (2025-2030)
4.1.3 Global Human Rabies Vaccination Sales Market Share by Type (2019-2030)
4.2 Global Human Rabies Vaccination Revenue by Type (2019-2030)
4.2.1 Global Human Rabies Vaccination Revenue by Type (2019-2024)
4.2.2 Global Human Rabies Vaccination Revenue by Type (2025-2030)
4.2.3 Global Human Rabies Vaccination Revenue Market Share by Type (2019-2030)
4.3 Global Human Rabies Vaccination Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Rabies Vaccination Sales by Application (2019-2030)
5.1.1 Global Human Rabies Vaccination Sales by Application (2019-2024)
5.1.2 Global Human Rabies Vaccination Sales by Application (2025-2030)
5.1.3 Global Human Rabies Vaccination Sales Market Share by Application (2019-2030)
5.2 Global Human Rabies Vaccination Revenue by Application (2019-2030)
5.2.1 Global Human Rabies Vaccination Revenue by Application (2019-2024)
5.2.2 Global Human Rabies Vaccination Revenue by Application (2025-2030)
5.2.3 Global Human Rabies Vaccination Revenue Market Share by Application (2019-2030)
5.3 Global Human Rabies Vaccination Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Human Rabies Vaccination Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Bavarian Nordic
6.2.1 Bavarian Nordic Corporation Information
6.2.2 Bavarian Nordic Description and Business Overview
6.2.3 Bavarian Nordic Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bavarian Nordic Human Rabies Vaccination Product Portfolio
6.2.5 Bavarian Nordic Recent Developments/Updates
6.3 Sanofi-Pasteur
6.3.1 Sanofi-Pasteur Corporation Information
6.3.2 Sanofi-Pasteur Description and Business Overview
6.3.3 Sanofi-Pasteur Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi-Pasteur Human Rabies Vaccination Product Portfolio
6.3.5 Sanofi-Pasteur Recent Developments/Updates
6.4 Chengda Bio
6.4.1 Chengda Bio Corporation Information
6.4.2 Chengda Bio Description and Business Overview
6.4.3 Chengda Bio Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengda Bio Human Rabies Vaccination Product Portfolio
6.4.5 Chengda Bio Recent Developments/Updates
6.5 KANGH
6.5.1 KANGH Corporation Information
6.5.2 KANGH Description and Business Overview
6.5.3 KANGH Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.5.4 KANGH Human Rabies Vaccination Product Portfolio
6.5.5 KANGH Recent Developments/Updates
6.6 Prcmise
6.6.1 Prcmise Corporation Information
6.6.2 Prcmise Description and Business Overview
6.6.3 Prcmise Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Prcmise Human Rabies Vaccination Product Portfolio
6.6.5 Prcmise Recent Developments/Updates
6.7 Henan Grand Biopharma
6.6.1 Henan Grand Biopharma Corporation Information
6.6.2 Henan Grand Biopharma Description and Business Overview
6.6.3 Henan Grand Biopharma Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Henan Grand Biopharma Human Rabies Vaccination Product Portfolio
6.7.5 Henan Grand Biopharma Recent Developments/Updates
6.8 Zhuoyi Biological
6.8.1 Zhuoyi Biological Corporation Information
6.8.2 Zhuoyi Biological Description and Business Overview
6.8.3 Zhuoyi Biological Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhuoyi Biological Human Rabies Vaccination Product Portfolio
6.8.5 Zhuoyi Biological Recent Developments/Updates
6.9 ZhongKe Biopharm
6.9.1 ZhongKe Biopharm Corporation Information
6.9.2 ZhongKe Biopharm Description and Business Overview
6.9.3 ZhongKe Biopharm Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZhongKe Biopharm Human Rabies Vaccination Product Portfolio
6.9.5 ZhongKe Biopharm Recent Developments/Updates
6.10 Ningbo Rongan Biological
6.10.1 Ningbo Rongan Biological Corporation Information
6.10.2 Ningbo Rongan Biological Description and Business Overview
6.10.3 Ningbo Rongan Biological Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ningbo Rongan Biological Human Rabies Vaccination Product Portfolio
6.10.5 Ningbo Rongan Biological Recent Developments/Updates
6.11 Indian Immunologicals
6.11.1 Indian Immunologicals Corporation Information
6.11.2 Indian Immunologicals Human Rabies Vaccination Description and Business Overview
6.11.3 Indian Immunologicals Human Rabies Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Indian Immunologicals Human Rabies Vaccination Product Portfolio
6.11.5 Indian Immunologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Vaccination Industry Chain Analysis
7.2 Human Rabies Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Vaccination Production Mode & Process
7.4 Human Rabies Vaccination Sales and Marketing
7.4.1 Human Rabies Vaccination Sales Channels
7.4.2 Human Rabies Vaccination Distributors
7.5 Human Rabies Vaccination Customers
8 Human Rabies Vaccination Market Dynamics
8.1 Human Rabies Vaccination Industry Trends
8.2 Human Rabies Vaccination Market Drivers
8.3 Human Rabies Vaccination Market Challenges
8.4 Human Rabies Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Rabies Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Rabies Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Rabies Vaccination Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Rabies Vaccination Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Human Rabies Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Rabies Vaccination Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Rabies Vaccination Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Rabies Vaccination Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Rabies Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Rabies Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Rabies Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of Human Rabies Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Rabies Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccination as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Rabies Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Rabies Vaccination Sales by Region (2019-2024) & (K Units)
Table 18. Global Human Rabies Vaccination Sales Market Share by Region (2019-2024)
Table 19. Global Human Rabies Vaccination Sales by Region (2025-2030) & (K Units)
Table 20. Global Human Rabies Vaccination Sales Market Share by Region (2025-2030)
Table 21. Global Human Rabies Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Rabies Vaccination Revenue Market Share by Region (2019-2024)
Table 23. Global Human Rabies Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Rabies Vaccination Revenue Market Share by Region (2025-2030)
Table 25. North America Human Rabies Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Rabies Vaccination Sales by Country (2019-2024) & (K Units)
Table 27. North America Human Rabies Vaccination Sales by Country (2025-2030) & (K Units)
Table 28. North America Human Rabies Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Rabies Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Rabies Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Rabies Vaccination Sales by Country (2019-2024) & (K Units)
Table 32. Europe Human Rabies Vaccination Sales by Country (2025-2030) & (K Units)
Table 33. Europe Human Rabies Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Rabies Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Rabies Vaccination Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Rabies Vaccination Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Human Rabies Vaccination Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Human Rabies Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Rabies Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Rabies Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Rabies Vaccination Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Human Rabies Vaccination Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Human Rabies Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Rabies Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Rabies Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Rabies Vaccination Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Human Rabies Vaccination Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Human Rabies Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Rabies Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Rabies Vaccination Sales (K Units) by Type (2019-2024)
Table 51. Global Human Rabies Vaccination Sales (K Units) by Type (2025-2030)
Table 52. Global Human Rabies Vaccination Sales Market Share by Type (2019-2024)
Table 53. Global Human Rabies Vaccination Sales Market Share by Type (2025-2030)
Table 54. Global Human Rabies Vaccination Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Rabies Vaccination Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Rabies Vaccination Revenue Market Share by Type (2019-2024)
Table 57. Global Human Rabies Vaccination Revenue Market Share by Type (2025-2030)
Table 58. Global Human Rabies Vaccination Price (US$/Unit) by Type (2019-2024)
Table 59. Global Human Rabies Vaccination Price (US$/Unit) by Type (2025-2030)
Table 60. Global Human Rabies Vaccination Sales (K Units) by Application (2019-2024)
Table 61. Global Human Rabies Vaccination Sales (K Units) by Application (2025-2030)
Table 62. Global Human Rabies Vaccination Sales Market Share by Application (2019-2024)
Table 63. Global Human Rabies Vaccination Sales Market Share by Application (2025-2030)
Table 64. Global Human Rabies Vaccination Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Rabies Vaccination Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Rabies Vaccination Revenue Market Share by Application (2019-2024)
Table 67. Global Human Rabies Vaccination Revenue Market Share by Application (2025-2030)
Table 68. Global Human Rabies Vaccination Price (US$/Unit) by Application (2019-2024)
Table 69. Global Human Rabies Vaccination Price (US$/Unit) by Application (2025-2030)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bharat Biotech Human Rabies Vaccination Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. Bavarian Nordic Corporation Information
Table 76. Bavarian Nordic Description and Business Overview
Table 77. Bavarian Nordic Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bavarian Nordic Human Rabies Vaccination Product
Table 79. Bavarian Nordic Recent Developments/Updates
Table 80. Sanofi-Pasteur Corporation Information
Table 81. Sanofi-Pasteur Description and Business Overview
Table 82. Sanofi-Pasteur Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi-Pasteur Human Rabies Vaccination Product
Table 84. Sanofi-Pasteur Recent Developments/Updates
Table 85. Chengda Bio Corporation Information
Table 86. Chengda Bio Description and Business Overview
Table 87. Chengda Bio Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Chengda Bio Human Rabies Vaccination Product
Table 89. Chengda Bio Recent Developments/Updates
Table 90. KANGH Corporation Information
Table 91. KANGH Description and Business Overview
Table 92. KANGH Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. KANGH Human Rabies Vaccination Product
Table 94. KANGH Recent Developments/Updates
Table 95. Prcmise Corporation Information
Table 96. Prcmise Description and Business Overview
Table 97. Prcmise Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Prcmise Human Rabies Vaccination Product
Table 99. Prcmise Recent Developments/Updates
Table 100. Henan Grand Biopharma Corporation Information
Table 101. Henan Grand Biopharma Description and Business Overview
Table 102. Henan Grand Biopharma Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Henan Grand Biopharma Human Rabies Vaccination Product
Table 104. Henan Grand Biopharma Recent Developments/Updates
Table 105. Zhuoyi Biological Corporation Information
Table 106. Zhuoyi Biological Description and Business Overview
Table 107. Zhuoyi Biological Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zhuoyi Biological Human Rabies Vaccination Product
Table 109. Zhuoyi Biological Recent Developments/Updates
Table 110. ZhongKe Biopharm Corporation Information
Table 111. ZhongKe Biopharm Description and Business Overview
Table 112. ZhongKe Biopharm Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. ZhongKe Biopharm Human Rabies Vaccination Product
Table 114. ZhongKe Biopharm Recent Developments/Updates
Table 115. Ningbo Rongan Biological Corporation Information
Table 116. Ningbo Rongan Biological Description and Business Overview
Table 117. Ningbo Rongan Biological Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ningbo Rongan Biological Human Rabies Vaccination Product
Table 119. Ningbo Rongan Biological Recent Developments/Updates
Table 120. Indian Immunologicals Corporation Information
Table 121. Indian Immunologicals Description and Business Overview
Table 122. Indian Immunologicals Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Indian Immunologicals Human Rabies Vaccination Product
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Human Rabies Vaccination Distributors List
Table 128. Human Rabies Vaccination Customers List
Table 129. Human Rabies Vaccination Market Trends
Table 130. Human Rabies Vaccination Market Drivers
Table 131. Human Rabies Vaccination Market Challenges
Table 132. Human Rabies Vaccination Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Rabies Vaccination
Figure 2. Global Human Rabies Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Rabies Vaccination Market Share by Type in 2023 & 2030
Figure 4. Vero Cell Product Picture
Figure 5. BHK Product Picture
Figure 6. Chick Embryo Cell Product Picture
Figure 7. Human Diploid Cells Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human Rabies Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Human Rabies Vaccination Market Share by Application in 2023 & 2030
Figure 11. Pre-exposure
Figure 12. Post-exposure
Figure 13. Global Human Rabies Vaccination Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Human Rabies Vaccination Market Size (2019-2030) & (US$ Million)
Figure 15. Global Human Rabies Vaccination Sales (2019-2030) & (K Units)
Figure 16. Global Human Rabies Vaccination Average Price (US$/Unit) & (2019-2030)
Figure 17. Human Rabies Vaccination Report Years Considered
Figure 18. Human Rabies Vaccination Sales Share by Manufacturers in 2023
Figure 19. Global Human Rabies Vaccination Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Human Rabies Vaccination Players: Market Share by Revenue in 2023
Figure 21. Human Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Human Rabies Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Human Rabies Vaccination Sales Market Share by Country (2019-2030)
Figure 24. North America Human Rabies Vaccination Revenue Market Share by Country (2019-2030)
Figure 25. United States Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Human Rabies Vaccination Sales Market Share by Country (2019-2030)
Figure 28. Europe Human Rabies Vaccination Revenue Market Share by Country (2019-2030)
Figure 29. Germany Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Human Rabies Vaccination Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Human Rabies Vaccination Revenue Market Share by Region (2019-2030)
Figure 36. China Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Human Rabies Vaccination Sales Market Share by Country (2019-2030)
Figure 46. Latin America Human Rabies Vaccination Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Human Rabies Vaccination Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Human Rabies Vaccination Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Human Rabies Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Human Rabies Vaccination by Type (2019-2030)
Figure 56. Global Revenue Market Share of Human Rabies Vaccination by Type (2019-2030)
Figure 57. Global Human Rabies Vaccination Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Human Rabies Vaccination by Application (2019-2030)
Figure 59. Global Revenue Market Share of Human Rabies Vaccination by Application (2019-2030)
Figure 60. Global Human Rabies Vaccination Price (US$/Unit) by Application (2019-2030)
Figure 61. Human Rabies Vaccination Value Chain
Figure 62. Human Rabies Vaccination Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
